v3.26.3
Description of Organization, Business Operations and Liquidity (Details Narrative) - USD ($)
6 Months Ended
Mar. 27, 2026
Dec. 16, 2025
Dec. 05, 2025
Oct. 01, 2025
Sep. 14, 2025
Dec. 20, 2024
Dec. 28, 2023
Sep. 27, 2023
Jan. 09, 2023
Jan. 04, 2023
Jun. 30, 2026
Jan. 31, 2026
Dec. 31, 2025
Jan. 04, 2024
Sep. 26, 2023
Jan. 08, 2022
Subsidiary, Sale of Stock [Line Items]                                
Date of incorporation                     Sep. 15, 2021          
Shares redeemed   69   917,814   3,403,976         6,204          
Ordinary share par value                     $ 0.0001   $ 0.0001      
Sale of stock price per share $ 12.99                              
Number of shares issued 6,135                              
Proceeds from issuance of IPO and private units                 $ 70,242,000              
Shares redeem for cash             2,160,774                  
Payments for deposits               $ 690,000                
Deposits   $ 1   $ 55,000   $ 55,000 $ 55,000           $ 5,021 $ 165,000    
Value of shares redeemed   $ 889.39   $ 11,362,537   $ 38,852,320.60 $ 23,302,146                  
Redemption price per share   $ 12.89   $ 12.38   $ 11.41 $ 10.78       $ 11.68   $ 11.50      
Investments held in trust account       $ 4,763,806.84   $ 15,240,284 $ 51,252,520.37       $ 4,804,622 $ 4,814,570.90 $ 4,800,584      
Ordinary shares outstanding 2,545,432 2,551,567   2,551,636   3,469,450 6,873,426       2,134,200   2,134,200      
Sale of stock description the Company held an extraordinary general meeting (the “Fifth Meeting”), solely with respect to voting on (i) the proposal to extend the date by which the Company must complete its initial business combination from April 4, 2026 to December 4, 2026, with all eight (8) extensions comprised of one month each and (ii) the proposal to amend the Company’s investment management trust agreement, dated as of December 30, 2022, by and between the Company and Equiniti Trust Company, LLC to allow the Company to extend the Termination Date up to eight (8) times, with each extension comprised of one month each from the Termination Date, or extended date, as applicable, to December 4, 2026, by providing five days’ advance notice to the trustee prior to the applicable Termination Date, or extended date, and depositing into the trust account $15,000 for each monthly extension until December 4, 2026.                              
Number of shares issued value $ 79,701.15                              
Deposit into trust account $ 4,776,621.79                              
Stock Issued During Period, Value, New Issues                     $ 80,590.54          
Ordinary shares subject to possible redemption                     411,232   417,436      
Cash                     $ 1,233   $ 1,233      
Working capital deficit                     4,591,305          
Loans payable                     1,262,500          
Outstanding borrowed amount                     892,301          
Promissory Note [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Notes payable current                             $ 690,000  
Deposits                     610,144          
Securities Purchase Agreements [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Number of shares issued         1,150,000                      
Agreed proceeds to issue and sell in private placement         $ 11,500,000                      
Purchase price per share         $ 10.00                      
Warrants to purchase of ordinary shares         2,300,000                      
Exercise price per share         $ 10.00                      
BC Meeting [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Shares redeem for cash     382,091                          
Sponsor [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Ordinary shares outstanding                               1,725,000
Sponsor [Member] | Promissory Note [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Notes payable current             $ 660,000                  
Deposits             $ 489,979                  
IPO [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Shares redeemed                   6,000,000            
Ordinary share par value                   $ 0.0001            
Sale of stock price per share                   $ 10.00            
Proceeds from sale of units                   $ 60,000,000            
Transaction cost                 4,892,699              
Payments for underwriting expense                 1,612,500   1,612,500          
Deferred underwriting commission                 2,415,000   $ 2,415,000          
Other offering costs                 $ 865,199              
Purchase price per share                     $ 0.35          
Exercise price per share                 $ 11.50              
Sale of stock description                 Each Right entitles the holder thereof to receive one-tenth (1/10) of one Ordinary Share upon the consummation of the initial Business Combination.              
Over-Allotment Option [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Shares redeemed                 900,000              
Sale of stock price per share                 $ 10.00              
Proceeds from sale of stock                 $ 9,000,000              
Private Placement [Member] | Sponsor [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Sale of stock price per share                   $ 10.00            
Number of shares issued                 38,700 370,500            
Proceeds from sale of private units                 $ 387,000 $ 3,705,000            
Sale of stock description                   Each Private Unit consists of one Ordinary Share, one Warrant and one Right, and is identical to the Units sold in the IPO except as described in the Company’s registration statement.